innovation
South Korea's Adel Signs up to $1.04 Billion Alzheimer's Drug Development Deal With Sanofi
Tesla Shares Jump as Musk Confirms Driverless Robotaxi Testing
HeadlinesUkraine Says Underwater Drones Hit Submarine, but Moscow Denies Damage
Bridgewater Warns Big Tech's Reliance on External Capital to Fund AI Boom Is 'dangerous'
Italian Firms Using AI Double in a Year but Still Small Minority
Date: December 15, 2025
ROME, Dec 15 (Reuters) - The number of Italian firms using artificial intelligence has doubled over the past year, a report showed on Monday, but the diffusion of the technology remains extremely low...
UBS Parts With Chief Tech Officer, Promises 'smooth' Integration Process
Date: December 15, 2025
BERLIN, Dec 15 (Reuters) - UBS' chief operations and technology officer, Mike Dargan, will leave the Swiss bank at the end of the month, the company said on Monday, as it reorganises the board to...
Oaktree-Backed Firm Unveils $1.2 Billion Amsterdam 'hyperscale' Data Centre Project
Date: December 15, 2025
By Lucy Raitano LONDON, Dec 15 (Reuters) - Oaktree Capital-backed firm Pure Data Centres said on Monday it plans to spend up to 1 billion euros ($1.17 billion) on an Amsterdam campus, in one of the...
STMicro Has Shipped 5 Billion Chips for Starlink in Past Decade; That Could Double by 2027
Date: December 15, 2025
By Nathan Vifflin Dec 15 (Reuters) - STMicroelectronics has shipped more than 5 billion radio-frequency antenna chips to Elon Musk's SpaceX for the Starlink satellite network, and chips delivered...
Italy Crafts Lab-Grown Snacks With Fruit Residues, Plant Cells and a 3D Printer
Date: December 15, 2025
ROME, Dec 15 (Reuters) - Scientists in Italy are developing sweet snacks with lab-grown plant cells and fruit residues, producing a material that a 3D printer can then process into 'pastries' with...
Sanofi Flags Second Delay to Fda Decision on Multiple Sclerosis Drug, Shares Fall
Date: December 15, 2025
Dec 15 (Reuters) - Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to a U.S. regulatory decision for its experimental multiple sclerosis drug and...